Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial.
Kayvon Modjarrad, Christine C Roberts, Kristin T Mills, Amy R Castellano, Kristopher Paolino, Kar Muthumani, Emma L Reuschel, Merlin L Robb, Trina Racine, Myoung-Don Oh, Claude Lamarre, Faraz I Zaidi, Jean Boyer, Sagar B Kudchodkar, Moonsup Jeong, Janice M Darden, Young K Park, Paul T Scott, Celine Remigio, Ajay P Parikh, Megan C Wise, Ami Patel, Elizabeth K Duperret, Kevin Y Kim, Hyeree Choi, Scott White, Mark Bagarazzi, Jeanine M May, Deborah Kane, Hyojin Lee, Gary Kobinger, Nelson L Michael, David B Weiner, Stephen J Thomas, Joel N Maslow
The Lancet. Infectious diseases 2020;19(9):1013-1022